Skip to main content
SpringerLink
Log in

Percutaneous Absorption and Anti-Inflammatory Effect of a Substance P Receptor Antagonist: Spantide II

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. There is accumulating evidence that neurogenic mediators such as substance P (SP) and α-melanocyte stimulating hormone (α-MSH) contribute to inflammation following chemical and thermal injuries or in disease conditions such as psoriasis and contact dermatitis. Spantide II is a peptide with a molecular weight of 1670.2 which binds to neurokinin-1 receptor (NKR-1) and blocks proinflammatory activities associated with SP. The aim of this study was to investigate in vitro permeation and distribution of spantide II through hairless rat skin and the anti-inflammatory effect of topically delivered spantide II in an allergic contact dermatitis (ACD) mouse model.

Methods. The in vitro permeation and distribution of spantide II with or without cysteine HCl (CH) as a penetration enhancer through hairless rat skin was studied using Franz diffusion cells. The anti-inflammatory effect of spantide II was studied by measuring the reduction of ACD in C57BL/6 mice after application of spantide II as a topical solution.

Results. The skin permeation experiments with or without cysteine HCl (as penetration enhancer) showed no detectable levels of span- tide II permeation across rat skin over a period of 48 h. Cysteine HCl significantly increased the distribution of spantide II in skin layers; also, the reduction in ACD response was significantly higher with the formulation containing cysteine HCl (p < 0.05). Spantide II at different concentrations showed a dose-dependent reduction of ACD response in mice.

Conclusions. The current study demonstrates that spantide II can effectively be delivered to epidermis and dermis to exert a significant anti-inflammatory activity on the reduction of inflammation in a mouse model of ACD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. K. Seiert and R. D. Granstein. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 28:97-103 (2002).

    Google Scholar 

  2. J. C. Ansel, A. H. Kaynard, C. A. Armstrong. J. E Olerud, N. W. Bunnett, and D. G. Payan. Skin-nervous system interactions. J. Invest. Dermatol. 106:198-204 (1996).

    Google Scholar 

  3. J. E. Parrillo and A. S. Fauci. Mechanisms of glucocorticoid action on immune processes. Annu. Rev. Pharmacol. Toxicol. 19:179-201 (1979).

    Google Scholar 

  4. A. N. Anigbogu and H. I. Maibach. Topical corticosteroid therapy. In L. Millikan (ed.), Drug Therapy in Dermatology, Basic and Clinical Dermatology. Marcel Dekker, New York, 2000, pp. 1-29.

    Google Scholar 

  5. T. E. Scholzen, T. Brzoska, D. H. Kalden, F. O'Reilly, C. A. Armstrong, T. A. Luger, and J. C. Ansel. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation. J. Invest. Dermatol. Symp. Proc 4:55-60 (1999).

    Google Scholar 

  6. J. R. Brown, P. Perry, S. Hefeneider, and A. C. Ansel. Neuropeptide modulation of keratinocyte cytokine production. In P. Oppenheim and D. Kluger (eds.), Molecular and Cellular Biology of Cytokines. Wiley-Liss, New York, 1990, pp. 451-456

    Google Scholar 

  7. T. Andoh, T. Nagasawa, M. Satoh, and Y. Kuraishi. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther. 286:1140-1145 (1998).

    Google Scholar 

  8. H. Inoue, N. Nagata, and Y. Koshihara. Involvement of substance P as a mediator in capsaicin-induced mouse ear edema. Inflamm. Res. 44(11):470-474 (1995).

    Google Scholar 

  9. X. J. Xu, J. X. Hao, Z. Wiesenfeld-Hallin, R. Hakanson, K. Folkers, and T. Hokfelt. Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic c-fiber stimulation in rat hindpaw. Neuroscience 42:731-737 (1991).

    Google Scholar 

  10. R. B. Meyer, W. Kreis, J. Eschbach, V. O'Mara, S. Rosen, and D. Sibalis. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharmacol. Ther. 44:607-612 (1988).

    Google Scholar 

  11. A. Ruland, J. Kreuter, and J. H. Rytting. Transdermal delivery of tetrapeptide hisetal (melanotropin (6-9). I. Effect of various penetration enhancers: In vitro study across hairless mouse skin. Int. J. Pharm. 101:57-61 (1974).

    Google Scholar 

  12. S. E. Cross and M. S. Roberts. Targeting local tissues by transdermal application: understanding drug physicochemical properties that best exploit protein binding and blood flow effects. Drug Dev. Res. 46:309-315 (1999).

    Google Scholar 

  13. B. M. Magnusson and P. Runn. Effect of penetration enhancers on the permeation of the thyrotropin releasing hormone analogue pGlu-3-methyl-His-Pro amide through human epidermis. Int. J. Pharm. 178:149-159 (1999).

    Google Scholar 

  14. B. M Magnusson. L. O. Koskinen, M. Koch, and K. Karlsson. Biological effects after percutaneous absorption of thyrotropin-releasing hormone and its analogue M-TRH. Peptides 22:73-79 (2001).

    Google Scholar 

  15. R. J. Babu, N. Kanikkannan, L. Kikwai, and M. Singh. Evaluation of sulfhydryl compounds as novel skin penetration enhancers. AAPS Pharm. Sci. 4(4):Abstract R6079 (2002). Available from http://www.aapspharmsci.org.

  16. Z. Y. Wang, D. M. Feng, Y. L. Wang, S. R. Tung, K. Wong, G. R. Strichartz, K. Folkers, and R. Hakanson. Pharmacological assessment of spantide II analogues. Eur. J. Pharmacol. 260:121-128 (1994).

    Google Scholar 

  17. Y. Wang, C. Hong, W. Chiu, and J. Fang. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int. J. Pharm. 224:89-104 (2001).

    Google Scholar 

  18. C. Surber, F. P. Schwarb, and E. W. Smith. Tape stripping technique. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Drugs – Cosmetics – Mechanisms – Methodology, Marcel Dekker, New York, 1999, pp. 395-409.

    Google Scholar 

  19. S. Grabbe, R. S. Bhardwaj, K. Mahnke, M. M. Simon, T. Schwarz, and T. A. Luger. Alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156:473-478 (1996).

    Google Scholar 

  20. R. J. Scheuplein and I. H. Blank. Permeability of the skin. Physiol. Rev. 51:702-747 (1971).

    Google Scholar 

  21. G. G. Hillebrand and V. Gartstein. Depilatory compositions. U.S. Patent No. US5897857, April 27, 1999.

  22. C. Weber, M. Podda, M. Rallis, J. J. Thiele, M. G. Traber, and L. Packer. Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Free Radic. Biol. Med. 22:761-769 (1997).

    Google Scholar 

  23. R. D. Ley and V. E. Reeve. Chemoprevention of ultraviolet radiation induced skin cancer. Environ. Health Perspect. 105:981-984 (1997).

    Google Scholar 

  24. B. A. Jurkiewicz, D. L. Bissett, and G. R. Buettner. Effect of topically applied tocopherol on ultraviolet radiation-mediated free radical damage in skin. J. Invest. Dermatol. 104:484-488 (1995).

    Google Scholar 

  25. L. L. Hruza and A. P. Pentland. Mechanisms of UV-induced inflammation. J. Invest. Dermatol. 100:35S-41S (1993).

    Google Scholar 

  26. N. Kanikkannan and M. Singh. Evaluation of sulfhydryl compounds as novel skin penetration enhancers. AAPS Pharm. Sci. 3(3): Abstract (2001). Available from http://www.aapspharmsci.org.

  27. P. Anand, D. R. Springall, M. A. Blank, D. Sellu, J. M. Ploak, and S. R. Bloom. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhydrisis. Br. J. Dermatol. 124:547-549 (1991).

    Google Scholar 

  28. C. Pincelli, F. Fantini, P. Romualdi, G. Lesa, and A. Giannetti. Skin levels of vasoactive intestinal peptidein atopic dermatitis. Arch. Dermatol. Res. 283:230-232 (1991).

    Google Scholar 

  29. W. R. Pfister and D. S. Hsieh. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. Med. Device Technol. 1:48-55 (1990).

    Google Scholar 

  30. R. O. Potts. Physical characterization of stratum corneum: the relationship of mechanical and barrier properties to lipid and protein structure. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery: Developmental Issues and Research Initiatives. Marcel Dekker, New York, 1989, pp. 23-57.

    Google Scholar 

  31. T. E. Scholzen, M. Steinhoff, P. Bonaccorsi, R. Klein, S. Amadesi, P. Geppetti, B. Lu, N. P. Gerard, J. E. Olerud, T. A. Luger, N. W. Bunnett, E. F. Grady, C. A. Armstrong, and J. C. Ansel. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J. Immunol. 166:1285-1291 (2001).

    Google Scholar 

  32. S. D. Brain. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 37:133-152 (1997).

    Google Scholar 

  33. T. E. Scholzen, C. A. Armstrong, N. W. Bunnett, T. A. Luger, J. E. Olerud, and J. C. Ansel. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp. Dermatol. 7:81-96 (1998).

    Google Scholar 

  34. B. W. Barry. Reflections on transdermal drug delivery. Pharm. Sci. Technol. Today 2:41-43 (1999).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Pharmaceutical Sciences, Florida A & M University, Tallahassee, Florida, 32307, USA

    R. Jayachandra Babu, Loice Kikwai, Narayanasamy Kanikkannan & Mandip Singh

  2. Department of Dermatology, Northwestern University, The Feinberg School of Medicine, Chicago, Illinois, 60611, USA

    Lasha T. Jaiani, Cheryl A. Armstrong & John C. Ansel

Authors
  1. R. Jayachandra Babu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Loice Kikwai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lasha T. Jaiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Narayanasamy Kanikkannan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cheryl A. Armstrong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John C. Ansel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mandip Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mandip Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Babu, R.J., Kikwai, L., Jaiani, L.T. et al. Percutaneous Absorption and Anti-Inflammatory Effect of a Substance P Receptor Antagonist: Spantide II. Pharm Res 21, 108–113 (2004). https://doi.org/10.1023/B:PHAM.0000012157.80716.73

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000012157.80716.73

Search

Navigation